Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR | Market Cap | 21.54B -19.1% |
| Revenue (ttm) | 7.66B +9.9% |
| Net Income | 803.87M +6.3% |
| EPS | 24.46 +7.2% |
| Shares Out | 32.44M |
| PE Ratio | 27.15 |
| Forward PE | 19.37 |
| Dividend | 2.75 (0.41%) |
| Ex-Dividend Date | Sep 12, 2025 |
| Volume | 34,145 |
| Average Volume | 71,505 |
| Open | 664.50 |
| Previous Close | 664.10 |
| Day's Range | 654.00 - 668.10 |
| 52-Week Range | 625.75 - 894.40 |
| Beta | -0.20 |
| RSI | 34.47 |
| Earnings Date | Feb 5, 2026 |
About Krsnaa Diagnostics
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves indivi... [Read more]
Financial Performance
In fiscal year 2025, Krsnaa Diagnostics's revenue was 7.17 billion, an increase of 15.74% compared to the previous year's 6.20 billion. Earnings were 776.08 million, an increase of 36.54%.
Financial StatementsNews
Why are Krsnaa Diagnostics shares down 3% today? Explained
Shares of Krsnaa Diagnostics were trading lower on Thursday, February 6, after the company reported a mixed set of Q3...
Krsnaa Diagnostics approves Rs 430 crore fundraise via NCDs
Krsnaa Diagnostics has announced that its Board of Directors has approved the issuance of unlisted, secured, redeemable, and transferable non-convertible...
Krsnaa Diagnostics shares jump over 3% as Q2 revenue rises 10.5% YoY to Rs 206 crore, net profit rose 21.9%
Krsnaa Diagnostics shares gained over 3% in early trade on Monday after the company posted a healthy set of numbers...
Krsnaa Diagnostics shares fall over 3% following Q1 results
Shares of Krsnaa Diagnostics Limited dropped 3.58% to Rs 836.05 on Tuesday, August 12, despite the company reporting strong financial performance for the first quarter of FY26. The decline is likely d...
Krsnaa Diagnostics gets Rajasthan High Court nod, to proceed with NHM lab services contract
Krsnaa Diagnostics Limited announced on Monday, July 7, that it has received a fresh Letter of Acceptance (LoA) from the National Health Mission (NHM), Rajasthan, to provide laboratory services under ...
Top stocks to buy today: Stock recommendations for April 23, 2025
Stock market recommendations: Anand Rathi Shares and Stock Brokers' DVP Mehul Kothari recommends buying SJVN, IDBI Bank, and Krsnaa Diagnostics.
Lab stops blood collection at 400 BMC hosps over pending dues
Krsnaa Diagnostics has suspended blood collection services at over 400 civic hospitals in Mumbai due to overdue payments totaling nearly Rs 10 crore, leaving patients in distress and hospitals in chao...
Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore
Krsnaa Diagnostics, a small-cap company in the healthcare services industry, has reported a solid financial performance for the second quarter of FY25. The company’s net sales reached ₹186.34 crore, m...
Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi
Krsnaa Diagnostics announced it has secured agreements with the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS) and Sadar Hospital, Ranchi. These public-private partnerships involve se...
Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare
Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki's oncology and cardiology hospitals. This partnership will ensu...
Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi
Krsnaa Diagnostics Limited has been awarded a Letter of Intent (LOI) by Sadar Hospital, Ranchi, Jharkhand, to establish a Public-Private Partnership (PPP) project. This contract involves commissioning...
Krsnaa Diagnostics acquires stake in India’s first PPP cancer and cardiac care hospitals
Krsnaa Diagnostics Ltd, one of India’s leading integrated diagnostic service providers, has made a strategic investment in Apulki Healthcare Private Limited, the country’s first Public-Private Partner...
Krsnaa Diagnostics share price surges over 3% after company agrees to acquire 23.53% stake in Apulki Healthcare
Krsnaa Diagnostics shares jumped more than 3% in morning trade after the company agreed to acquire 23.53% stake in Apulki Healthcare Private Limited. Krsnaa Diagnostics Limited will pay a cash conside...